Showing results (311-320 of 371) with videos related to
Sort By:
Pageof 38
Neurochemistry International|August 1, 1997
Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's diseaseD Offen, I Ziv, A Barzilai, et al.Neuroscience Letters|March 28, 1994
Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's diseaseI Ziv, E Melamed, N Nardi, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 7, 2026
Early reduction in unplanned healthcare utilization following vagus nerve stimulation for pediatric epilepsyRakesh A Murugesan, Samuel B Tomlinson, Susan E Melamed, et al.Clinical Chemistry|August 1, 1984
Estimation of unconjugated, conjugated, and "delta" bilirubin fractions in serum by use of two coated thin filmsM W Sundberg, J J Lauff, J S Weiss, et al.The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 28, 2025
Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health SystemMegan L Miller, Nathan D Seligson, Benjamin Q Duong, et al.Journal of Neural Transmission. Supplementum|January 1, 1997
Induction of mitosis-related genes during dopamine-triggered apoptosis in sympathetic neuronsA Shirvan, I Ziv, A Barzilai, et al.The Journal of Biological Chemistry|April 6, 2001
Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathwaysD Daily, A Vlamis-Gardikas, D Offen, et al.The Journal of Biological Chemistry|October 18, 2000
Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1D Daily, A Vlamis-Gardikas, D Offen, et al.Lancet (London, England)|March 16, 2005
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trialO Rascol, D J Brooks, E Melamed, et al.Neurology|October 22, 1998
Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channelsD Offen, S Halevi, D Orion, et al.Pageof 38